AHA Coding Clinic® for ICD-9 - 2005 Issue 4; VOLUME 3 NEW/REVISED CODES
Infusion of Immunosuppressive Antibody Therapy
Effective October 1, 2005, a new code has been created to identify infusion of immunosuppressive antibodies. Immunosuppressive antibody therapies immunomodulate and prevent the immunologic activity against foreign antigens present on transplanted organs. Immunosuppression is used in solid organ transplantation to prevent rejection in the induction phase, as well as the maintenance phase, and can be used to reverse an ongoing rejection episode. The induction phase occurs prior to, during, or immediately after surgical transplantation. Immunosuppressive antibody therapy usually begins at the time of the transplant. The therapy is typically administered via the peripheral or central vein. In contrast to...
Subscribe or sign in to view the full article.
Article Overview
This premium article reviews a coding change effective October 1, 2005 involving infusion of immunosuppressive antibody therapy in the setting of solid organ transplantation. It discusses the clinical context for induction and maintenance immunosuppression, the role of antibody therapies in preventing rejection, and the general distinction between therapy types used during transplantation care. The content is intended for coding professionals and others who need to understand what the article covers and why the update matters without revealing the full premium guidance.
Why This Topic Matters
Transplant-related infusion services are highly specific and often depend on precise documentation and timing. Understanding the scope of this update helps coders, billers, and compliance staff identify when the article is relevant to transplant infusion reporting.
What You Will Learn
- The clinical setting in which immunosuppressive antibody infusion therapy is used
- How the article frames induction-phase and maintenance-phase transplant care
- The general categories of antibody therapy discussed in relation to transplantation coding
- The significance of the October 1, 2005 coding update
Who Should Read This
- Medical coders
- Coding auditors
- Transplant program staff
- Revenue cycle professionals
- Compliance teams
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com